is semaglutide banned in louisiana lawmakers are considering a bill that would expand Medicaid access to GLP-1 drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Louisiana allows telehealth obesity care

GLP-1 enhances renal function by vasodilating the kidney vessels, increasing blood flow and lowering angiotensin II, which are important for controlling vascular tone

Better Blood Sugar Control Improved regulation of blood sugar levels means your body is better able to use energy efficiently

doi: 10.1038/nature23270

As with Mounjaro, gastrointestinal side effects were the most common but generally mild

Any concerns of potential risk for suicidal ideations associated with semaglutide can be of critical importance. Semaglutide lowers suicidal ideation risk There were 52,783 adults with overweight or obesity and no history of suicidal ideation who received semaglutide matched with 52,783 adults who received a non-GLP-1 receptor agonist for the treatment of obesity